Evidence map›Paper›PMID 31199179›Full record

ArticlemAbs2019

L

Chang-Ai Xu, Andrew Z Feng, Charan K Ramineni, Matthew R Wallace, Elizabeth K Culyba, Kevin P Guay, Kinjal Mehta, Robert Mabry, Stephen Farrand, Jin Xu and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mAbs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Chang-Ai XuJounce Therapeutics , Cambridge , MA , USA.ORCID 0000-0003-3587-2215
Andrew Z FengChemistry Department, University of Massachusetts Lowell , Lowell , MA , USA.ORCID 0000-0003-1073-0704
Charan K RamineniChemistry Department, University of Massachusetts Lowell , Lowell , MA , USA.ORCID 0000-0003-2251-1787
Matthew R WallaceJounce Therapeutics , Cambridge , MA , USA.ORCID 0000-0002-4874-9075
Elizabeth K CulybaJounce Therapeutics , Cambridge , MA , USA.ORCID 0000-0002-2812-764X
Kevin P GuayJounce Therapeutics , Cambridge , MA , USA.ORCID 0000-0002-3468-942X
Kinjal MehtaJounce Therapeutics , Cambridge , MA , USA.ORCID 0000-0002-1926-4263
Robert MabryJounce Therapeutics , Cambridge , MA , USA.ORCID 0000-0002-4756-9021
Stephen FarrandJounce Therapeutics , Cambridge , MA , USA.ORCID 0000-0003-0406-9139
Jin XuChemistry Department, University of Massachusetts Lowell , Lowell , MA , USA.
Jianwen FengJounce Therapeutics , Cambridge , MA , USA.
University of Massachusetts Lowell · USBiolog (United States) · USUniversity of Massachusetts Chan Medical School · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IgG

Indexed as

Complementarity Determining RegionsGlycineHumansHydrogen-Ion ConcentrationHydrolysisImmunoglobulin GImmunoglobulin Heavy ChainsMutationPeptide FragmentsProtein AggregatesProtein BindingProtein ConformationProtein Interaction Domains and MotifsProtein StabilityProteolysisComplementarity Determining RegionsGlycineImmunoglobulin GImmunoglobulin Heavy ChainsPeptide FragmentsProtein Aggregatesacidic stressantibodyC-terminal cleavagedomain interactionmutationstability

Identifiers

PMID31199179
PMCPMC6748598
OpenAlexW2952833128

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.